1. Home
  2. SILO vs SBFM Comparison

SILO vs SBFM Comparison

Compare SILO & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • SBFM
  • Stock Information
  • Founded
  • SILO 2010
  • SBFM 2006
  • Country
  • SILO United States
  • SBFM United States
  • Employees
  • SILO N/A
  • SBFM N/A
  • Industry
  • SILO Apparel
  • SBFM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SILO Consumer Discretionary
  • SBFM Health Care
  • Exchange
  • SILO Nasdaq
  • SBFM Nasdaq
  • Market Cap
  • SILO 8.0M
  • SBFM 6.7M
  • IPO Year
  • SILO N/A
  • SBFM N/A
  • Fundamental
  • Price
  • SILO $0.54
  • SBFM $1.77
  • Analyst Decision
  • SILO
  • SBFM Strong Buy
  • Analyst Count
  • SILO 0
  • SBFM 1
  • Target Price
  • SILO N/A
  • SBFM $7.00
  • AVG Volume (30 Days)
  • SILO 869.8K
  • SBFM 2.2M
  • Earning Date
  • SILO 11-12-2025
  • SBFM 11-12-2025
  • Dividend Yield
  • SILO N/A
  • SBFM N/A
  • EPS Growth
  • SILO N/A
  • SBFM N/A
  • EPS
  • SILO N/A
  • SBFM N/A
  • Revenue
  • SILO $72,102.00
  • SBFM $36,341,741.00
  • Revenue This Year
  • SILO $1.86
  • SBFM $21.12
  • Revenue Next Year
  • SILO N/A
  • SBFM $44.89
  • P/E Ratio
  • SILO N/A
  • SBFM N/A
  • Revenue Growth
  • SILO N/A
  • SBFM 19.22
  • 52 Week Low
  • SILO $0.40
  • SBFM $1.17
  • 52 Week High
  • SILO $3.37
  • SBFM $3.90
  • Technical
  • Relative Strength Index (RSI)
  • SILO 40.10
  • SBFM 50.94
  • Support Level
  • SILO $0.50
  • SBFM $1.81
  • Resistance Level
  • SILO $0.59
  • SBFM $2.13
  • Average True Range (ATR)
  • SILO 0.05
  • SBFM 0.17
  • MACD
  • SILO -0.00
  • SBFM -0.03
  • Stochastic Oscillator
  • SILO 54.31
  • SBFM 24.14

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

Share on Social Networks: